THURSDAY, AUGUST 15, 2019
DERRICK GOLF & WINTER CLUB

Lunch & Registration 11:00 a.m.
Shotgun starts at 1:00 p.m.

PRESENTED BY

AN EVENT BY

CO-HOSTED BY

GRANT FUHR

31 Years of Giving

Thanks to volunteers and donors like you, the Cross Cancer Institute
Golf Classic has raised more than $15million in 30 years.

In 2019, #31 Grant Fuhr will co-host the Day. The magic #31 and his teammate will lead us to a different type of victory that will channel funds directly to treatments to make life better for Albertans facing this disease.

Glenn Anderson and Grant Fuhr are inspiring champions who play to win.

Over 16 seasons in more than 1,100 NHL games, Glenn Anderson made history. He came through under pressure and earned a spot in the Hockey Hall of Fame, along with six other Oilers. Between 1984 and 1994, he won six Stanley Cups. Anderson scored five overtime playoff goals, placing him on an esteemed list, just behind Maurice “Rocket” Richard (who scored six) and Joe Sakic (eight). Anderson retired in 1996. 

Between 1984 and 1990, Grant Fuhr led the Oilers to five Stanley Cups. During the 1983-84 season, he set the record for the most points by a goaltender in one season. In 1987, he earned the Vezina Trophy as the league’s best goaltender. Fuhr topped the league with 4,304 minutes of play and 40 wins. He retired in 2000 after 868 games, 403 wins and 19 NHL seasons. In 2003, Fuhr was inducted into the Hockey Hall of Fame.

Glenn Anderson and Grant Fuhr are inspiring champions who play to win.

The Cure Cancer Foundation is a new chapter in tournament history. It’s a grassroots movement to generate funding for initiatives at the Cross Cancer Institute—including research, diagnosis, treatment and patient care. We are passionate about finding a cure for cancer, while enhancing the lives of Albertans dealing with the disease. Dedicated volunteerism can maximize the impact of all the funds we raise.

In 2019, funds raised will go to multiple myeloma cancer research and to Dr. Michael Weinfeld and his research team. Cancer tumours can resist radiation and chemotherapy. They survive treatment by repairing their own DNA. Dr. Weinfeld’s team is developing new drugs that will stop this repair process. Treatment will become more effective with fewer side effects.

 

Committee Members

CO-CHAIRMAIN

Darren Baumgardner

Peter Wilkes

Guy Mersereau

 

Brian Anstice

Tim Boston

Jennifer Broda

Ryan Christensen

Brendan Connolly

Sean Curran

Darryl Boessenkool

Jeremy Fearnley

Bryn Griffiths

Brad Hainstock

Dean Heuman

Peter Inglis

Ken Jurinas

Lylle Kephart

Harry Kipnes

Blaine MacMillan

Kris Mauthe

Don McNabb

Simon Reese

Brian Samletzki

John Sexsmith

Dave Smith

Barrie Stafford

Darin Stuckey